Michelle A. Peluso - 26 Feb 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Michelle A. Peluso
Issuer symbol
CVS
Transactions as of
26 Feb 2022
Net transactions value
-$1,315,119
Form type
4
Filing time
01 Mar 2022, 16:58:43 UTC
Previous filing
10 Jan 2022
Next filing
05 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability $1,315,119 -12,609 -46% $104.30 14,911 26 Feb 2022 Direct F1
holding CVS Common Stock (RSU) 82,563 26 Feb 2022 Direct F2
holding CVS Common Stock (PSUs) 96,277 26 Feb 2022 Direct
holding CVS Common Stock (PSUs) 50,875 26 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 86,386 26 Feb 2022 Common Stock 86,386 $74.30 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.
F2 Consists of Restricted Stock Unit awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 02/26/2022.
F3 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.